Literature DB >> 1392417

Investigations into Ro-specific antibody-associated congenital cardiac conduction defects.

T Dörner1, F Hiepe, B Göldner, E Apostoloff.   

Abstract

Forty-two babies with different congenital cardiac conduction defects, and in 12 cases the mothers, were tested for autoantibodies to Ro, La, U1RNP and Sm. Ro-specific antibodies were detected most frequently. They were to be found in 16 sera from infants and in 8 maternal serum samples. The occurrence of anti-Ro was associated preferentially with several atrioventricular conduction blocks. The sex relation of anti-Ro associated congenital heart block did not show a typical preference (6 male/10 female). At the time of giving birth, 5 anti-Ro-positive mothers did not have any clinical symptoms of rheumatic autoimmune diseases. Three of them had a first degree atrioventricular block. Our findings indicate that all pregnant women at risk for anti-Ro like connective tissue disease or cardiac conduction defects should be tested for these autoantibodies because of the suspicion of cardiac conduction abnormalities in the offspring. Anti-Ro-positive infants should be examined for structural heart disease by echocardiography.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392417     DOI: 10.1007/bf00210230

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  29 in total

1.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].

Authors:  F Hiepe; S T Kiessig; K Yamamoto; G Prokop; F Mielke; A Lukowsky; B Schlaak; T Miyamoto; E Apostoloff
Journal:  Z Rheumatol       Date:  1990 Sep-Oct       Impact factor: 1.372

3.  Development of a solid phase enzyme immunoassay for the detection of anti-Ro autoantibodies.

Authors:  T Dörner; F Hiepe; F Mielke; S T Kiessig; A Lukowsky; E Apostoloff
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

4.  The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies.

Authors:  F Franceschini; M T Bertoli; M Martinelli; A Tincani; A Malagoli; D Faden; M Tarantini; G Balestrieri; R Cattaneo
Journal:  J Rheumatol       Date:  1990-03       Impact factor: 4.666

5.  Anti-Ro (SSA) and anti-La (SSB) antibodies in lupus erythematosus and in Sjögren's syndrome.

Authors:  L A Lee
Journal:  Arch Dermatol       Date:  1988-01

6.  Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.

Authors:  D Logar; T Kveder; B Rozman; J Dobovisek
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

Review 7.  Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature.

Authors:  R M Watson; A T Lane; N K Barnett; W B Bias; F C Arnett; T T Provost
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

8.  Autoantibodies to SS-A/Ro in infants with congenital heart block.

Authors:  B R Reed; L A Lee; C Harmon; R Wolfe; J Wiggins; C Peebles; W L Weston
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

9.  Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins.

Authors:  W M Behan; P O Behan; J Gairns
Journal:  Br Heart J       Date:  1987-02

10.  Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus.

Authors:  M D Lockshin; E Bonfa; K Elkon; M L Druzin
Journal:  Arthritis Rheum       Date:  1988-06
View more
  2 in total

Review 1.  Congenital complete atrioventricular block.

Authors:  N J Kertesz; A L Fenrich; R A Friedman
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Role of calcium channels in congenital heart block.

Authors:  E Karnabi; M Boutjdir
Journal:  Scand J Immunol       Date:  2010-09       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.